Evidence map›Paper›PMID 39036074›Full record

ArticleBioengineering & translational medicine2024

Feasibility of engineered

Veronica A Montgomery, Amy J Wood-Yang, Mark P Styczynski, Mark R Prausnitz

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioengineering & translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Living Microbial Drugs.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  2. Toward the Next Generation of In Silico Modeling of Dynamic Host-Microbiota Interactions in the Skin.JID innovations : skin science from molecules to population health · 2025
    Review
  3. Review
  4. Feasibility of engineeredBioengineering & translational medicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Veronica A MontgomeryWallace H. Coulter Department of Biomedical Engineering at Emory University and Georgia Tech Georgia Institute of Technology Atlanta Georgia USA.ORCID https://orcid.org/0009-0003-1757-9733
Amy J Wood-YangSchool of Chemical and Biomolecular Engineering Georgia Institute of Technology Atlanta Georgia USA.ORCID https://orcid.org/0000-0002-6219-8927
Mark P StyczynskiSchool of Chemical and Biomolecular Engineering Georgia Institute of Technology Atlanta Georgia USA.ORCID https://orcid.org/0000-0002-1479-6658
Mark R PrausnitzWallace H. Coulter Department of Biomedical Engineering at Emory University and Georgia Tech Georgia Institute of Technology Atlanta Georgia USA.ORCID https://orcid.org/0000-0002-9076-8448

Funding

Synthetic biological systems for protein detectionR01EB034301 · NIBIB · GEORGIA INSTITUTE OF TECHNOLOGY · PI Mark Philip-Walter Styczynski · 2023 to 2026
$1.4M
NIBIB NIH HHS R01 EB034301
6 · The paper itself

Abstract

Non-adherence to medication is a major challenge in healthcare that results in worsened treatment outcomes for patients. Reducing the frequency of required administrations could improve adherence but is challenging for topical drug delivery due to the generally short residence time of topical formulations on the skin. In this study, we sought to determine the feasibility of developing a microbiome-based, long-acting, topical delivery platform using

Indexed as

Bacillus subtilisengineered live biotherapeuticsskin microbiometopical drug delivery

Identifiers

PMID39036074
PMCPMC11256169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.